Loading clinical trials...
Loading clinical trials...
A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgeries
Conditions
Interventions
Fibrin Sealant Grifols
Surgicel®
Locations
33
United States
224
Loma Linda, California, United States
214
Los Angeles, California, United States
213
New Haven, Connecticut, United States
223
Augusta, Georgia, United States
228
Chicago, Illinois, United States
227
Goshen, Indiana, United States
Start Date
March 1, 2013
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
February 8, 2017
Lead Sponsor
Instituto Grifols, S.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions